NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?

Ingram, John R. ORCID: https://orcid.org/0000-0002-5257-1142 and Burton, T. 2017. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics? British Journal of Dermatology 176 (2) , pp. 281-282. 10.1111/bjd.15255

Full text not available from this repository.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Publisher:	Wiley-Blackwell
ISSN:	0007-0963
Date of Acceptance:	27 February 2017
Last Modified:	21 Oct 2022 07:41
URI:	https://orca.cardiff.ac.uk/id/eprint/100495

Citation Data

Cited 8 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item